Occupational Therapy for Age-Related Macular Degeneration

Phase < 1

Recruiting

Led By Michelle Dowling, OTD

Research Sponsored by MCPHS University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up results from the medicog will be determined on day 1 and will be obtained 4 weeks later

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to find out if educating individuals with AMD about using additional lighting, contrast enhancements, larger print instructions, smart apps, and organizational strategies can help them better manage their medications. Participants will receive

Who is the study for?

This trial is for individuals with Age-Related Macular Degeneration (AMD) who are receiving eye care services at the MCPHS School of Optometry in Worcester. Participants will allow their anonymous data to be used for research and are interested in learning how certain strategies might improve their medication management.

What is being tested?

The study tests if occupational therapy interventions like additional lighting, enhanced contrast, enlarged print instructions, smart apps, and organizational strategies can help people with AMD manage medications better and make more effective use of their vision.

What are the potential side effects?

There may not be direct side effects from participating as this trial involves educational strategies rather than medical treatments. However, participants may experience frustration or fatigue while learning new techniques.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ results from the revised-self-report assessment of functional visual performance assessment will be determined on day 1 and 4 weeks later

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~results from the revised-self-report assessment of functional visual performance assessment will be determined on day 1 and 4 weeks later

This trial's timeline: 3 weeks for screening, Varies for treatment, and results from the revised-self-report assessment of functional visual performance assessment will be determined on day 1 and 4 weeks later for reporting.